Release date: June 2007
Expiration date: June 30, 2008
Estimated time to complete activity: 30 minutes
Sponsored by Curatio CME Institute LLC
Support for this activity has been provided through an educational grant from Genentech, Inc.
Activity Overview
New data on the use of biologics has emerged in 2006. The purpose of this meeting report is to present an overview of salient developments in the use of biologics for patients with moderate to severe psoriasis.
Target Audience
This activity has been designed to meet the educational needs of physicians and other health care professionals involved in the care of patients with psoriasis.
Learning Objectives
Upon completion of this activity, participants should be able to: - Review clinical trial data regarding the use of biologics for the treatment of psoriasis
- Evaluate updated efficacy and safety data regarding biologic therapies for psoriasis
- Assess studies and case reports describing various treatment strategies for difficult-to-treat psoriasis
Faculty Editor
Alan Menter, MD
Chief, Division of Dermatology
Baylor University Medical Center
Clinical Professor of Dermatology
UT Southwestern Medical School
Dallas, Texas
Accreditation Statement
Curatio CME Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Curatio CME Institute designates this educational activity for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Method of Participation
There are no fees for participating in this CME activity. To receive credit during the period June 2007 to June 30, 2008, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, (3) complete the posttest, and (4) complete the activity evaluation form, including the certificate information section.
Media
The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.
Disclosure
In accordance with the ACCME’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below:
Alan Menter, MD has disclosed the following relevant financial relationship(s):
Grant: Abbott Laboratories, Allergan, Amgen, Astellas, Centocor, Cephalon, Collagenex, CombinatoRx, Connetics, Dow, Ferndale, Galderma, Genentech, Leo, Medicis, Photocure, Pierre Fabre, 3M Pharmaceuticals, UCB Pharma, XOMA
Investigator: Abbott Laboratories, Allergan, Amgen, Astellas, Centocor, Cephalon, Collagenex, CombinatoRx, Connetics, Dow, Ferndale, Galderma, Genentech, Leo, Medicis, Photocure, Pierre Fabre, 3M Pharmaceuticals, UCB Pharma, Warner Chilcott, Wyeth, XOMA
Honorarium: Abbott Laboratories, Allergan, Amgen, Astellas, Centocor, Cephalon, Connetics, Galderma, Genentech, UCB Pharma, Warner Chilcott, Wyeth
Consultant: Abbott Laboratories, Allergan, Amgen, Astellas, Centocor, Cephalon, Collagenex, UCB Pharma, Warner Chilcott, Wyeth
Speaker: Abbott Laboratories, Amgen, Centocor, Warner Chilcott, Wyeth
Dr. Menter discusses the unlabeled or investigational use of a commercial product.
Shari J. Dermer, PhD, Medical Director, Curatio CME Institute, has disclosed no relevant financial relationships.
Jonathan S. Simmons, ELS, Managing Editor, Curatio CME Institute, has disclosed no relevant financial relationships.
Disclaimer
The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
Unapproved Product Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Curatio CME Institute and Genentech, Inc. do not recommend the use of any agent outside the labeled indications.
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Curatio CME Institute or Genentech, Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Hardware/Software Requirements - Version 5.0 or higher for Microsoft Internet Explorer or Netscape 6 or higher for your internet browser
- If using a MAC computer system and are experiencing technical issues, we suggest downloading the latest version of Firefox for Mac
Contact Information
PsoriasisTx
100 Campbell Boulevard
Suite 103
Exton, PA 19341
editor@psoriasistx.com
Policy on Privacy and Confidentiality
Curatio CME Institute makes every effort to protect the privacy of PsoriasisTx users; user information is used only to maintain records as required by the American Medical Association (AMA) and the ACCME.
Curatio CME Institute does not require individuals to register to use PsoriasisTx; registration is only required for physicians, health care professionals, and other users to participate in and receive CME/CE credit for accredited educational programs hosted on PsoriasisTx.
Curatio CME Institute is required by the AMA and the ACCME (and occasionally by other accrediting organizations) to collect user information that will allow Curatio CME Institute to issue a CME/CE certificate. Curatio CME Institute is required to keep this information on file for up to 6 years. The information is stored in a secure database and used only to verify individual participation in a CME/CE activity and to reissue a certificate if a user’s original certificate is lost or misplaced.
Information gathered through PsoriasisTx will not be released to any other company or organization for any purpose; this information remains confidential. At the end of the mandatory 6-year period, these records will be permanently destroyed.
Curatio CME Institute uses Web site tracking software to determine how PsoriasisTx is used. This information helps Curatio CME Institute determine the best strategies for improving PsoriasisTx and better meeting the needs of its users. This software does not identify individual users.
PsoriasisTx does not employ cookies or any other software that violates a user's privacy.
If you have any questions about PsoriasisTx or any Curatio CME Institute policies, you may contact us at editor@psoriasistx.com.
Thank you for using PsoriasisTx.
|
 |
|
REGISTER NOW
